Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part 11 Is "Unnecessarily Burdensome" And Should Be Revoked – Industry Group

This article was originally published in The Pink Sheet Daily

Executive Summary

Regulation of systems for electronic record keeping and electronic signatures can be achieved through existing law and predicate rules, the Industry Coalition on Part 11 asserts in citizen's petition.

You may also be interested in...



FDA To Inspect Industry's Electronic Record Keeping Systems

Pharma companies may have more to worry about than potential GMP violations when FDA inspectors show up at their door. The agency recently announced that it would begin conducting inspections to determine if industry is in compliance with the regulation governing electronic records and electronic signatures

Injectable Sterility Recalls Decline To Eight In 2004

Drug recall totals for 2004 dropped to their lowest levels in five years, helped by a sharp decline in sterility assurance-related problems among injectables. Overall, 170 drug products were included in FDA’s recall listings during 2004.

Topics

UsernamePublicRestriction

Register

PS060679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel